893640-46-5 Usage
General Description
6-M-tolylpyridin-3-ylamine is a chemical compound with the molecular formula C14H13N3. It is a member of the pyridine family, and its structure consists of a pyridine ring with a 6-methyl tolyl group and an amine group attached at the 3-position. 6-M-tolylpyridin-3-ylamine is used in the synthesis of pharmaceuticals and agrochemicals, and it has been found to exhibit antiproliferative and anti-inflammatory properties. It is also a versatile building block for the preparation of various heterocyclic compounds. Its unique structure and diverse reactivity make it a valuable tool in organic synthesis and medicinal chemistry research.
Check Digit Verification of cas no
The CAS Registry Mumber 893640-46-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,3,6,4 and 0 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 893640-46:
(8*8)+(7*9)+(6*3)+(5*6)+(4*4)+(3*0)+(2*4)+(1*6)=205
205 % 10 = 5
So 893640-46-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2/c1-9-3-2-4-10(7-9)12-6-5-11(13)8-14-12/h2-8H,13H2,1H3
893640-46-5Relevant articles and documents
WNT PATHWAY MODULATORS
-
Paragraph 0251; 0252; 0269; 0270, (2015/07/07)
The present invention relates to dihydropyrazolo[l,5-a]pyrimidine compounds of formula I, defined herein, as WNT pathways modulators, processes for making them, and pharmaceutical compositions comprising them. Methods of treatment of conditions mediated by WNT pathway signalling including cancer, fibrosis, stem cell and diabetic retinopathy, rheumatoid arthritis, psoriasis and myocardial infarction, comprising the compounds of formula I are also provided.
AGENT FOR TREATMENT OF EYE DISEASES
-
Paragraph 0081; 0089, (2013/08/15)
The present invention provides agents effective to treat eye diseases, pharmaceutical compositions comprising them, methods for preparing pharmaceuticals for treatment of eye diseases comprising using the agents, use of the agents in manufacture of pharma
